R.J.G. wrote:Thanks for those comments Dave... very interesting perspective.
I know that in the new year I'll be paying attention to see if some of the VC money that has been playing the social media game over the last several years swings into biotech following some of the disappointing IPOs last year in that market.
It's much more complicated than just saying "biotech" . . . that's part of the problem. There are so many little niche's for companies, and they are in many cases not even similar to each other.
One niche that has been "poised" for dramatic growth is the bio-energy or bio-based chemical arena -- perhaps making valuable products like fuels or specialty chemicals out of waste materials like cellulose and so forth. When there are public disappointments (here, a couple of companies gave poor results and had layoffs, etc) it affects that entire niche.
I'm excited by so many young ventures that I've seen, worked with, or just read about. But, the money doesn't always flow uniformly across the world of biotech. It's such a big word.
"I can't understand why people are frightened of new ideas. I'm frightened of the old ones.”